Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

98 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
KM-416, a novel phenoxyalkylaminoalkanol derivative with anticonvulsant properties exerts analgesic, local anesthetic, and antidepressant-like activities. Pharmacodynamic, pharmacokinetic, and forced degradation studies.
Kubacka M, Rapacz A, Sałat K, Filipek B, Cios A, Pociecha K, Wyska E, Hubicka U, Żuromska-Witek B, Kwiecień A, Marona H, Waszkielewicz AM. Kubacka M, et al. Among authors: wyska e. Eur J Pharmacol. 2020 Nov 5;886:173540. doi: 10.1016/j.ejphar.2020.173540. Epub 2020 Sep 5. Eur J Pharmacol. 2020. PMID: 32896552
Influence of the CB1 and CB2 cannabinoid receptor ligands on the activity of atypical antidepressant drugs in the behavioural tests in mice.
Poleszak E, Wośko S, Sławińska K, Wyska E, Szopa A, Świąder K, Wróbel A, Doboszewska U, Wlaź P, Wlaź A, Serefko A. Poleszak E, et al. Among authors: wyska e. Pharmacol Biochem Behav. 2020 Jan;188:172833. doi: 10.1016/j.pbb.2019.172833. Epub 2019 Nov 27. Pharmacol Biochem Behav. 2020. PMID: 31785246 Free article.
Ligands of the CB2 cannabinoid receptors augment activity of the conventional antidepressant drugs in the behavioural tests in mice.
Poleszak E, Wośko S, Sławińska K, Wyska E, Szopa A, Sobczyński J, Wróbel A, Doboszewska U, Wlaź P, Wlaź A, Szponar J, Skałecki P, Serefko A. Poleszak E, et al. Among authors: wyska e. Behav Brain Res. 2020 Jan 27;378:112297. doi: 10.1016/j.bbr.2019.112297. Epub 2019 Oct 15. Behav Brain Res. 2020. PMID: 31626848 Free article.
98 results